​
​

Trevi Therapeutics Ownership | Who Owns Trevi Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Trevi Therapeutics Ownership Summary

Trevi Therapeutics is owned by 57.52% institutional investors, 1.18% insiders, and 41.30% retail investors. Nea management company is the largest institutional shareholder, holding 11.43% of TRVI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.31% of its assets in Trevi Therapeutics shares.

TRVI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTrevi Therapeutics57.52%1.18%41.30%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company11.37M11.43%$33.88M
Frazier life sciences management7.38M7.42%$22.00M
Rubric capital management lp5.03M5.05%$14.98M
Viking global investors lp4.40M4.42%$13.11M
Vr adviser3.42M3.44%$10.20M
Blackrock3.14M3.15%$9.34M
Logos global management lp2.80M2.81%$8.34M
Opaleye management2.65M2.66%$7.88M
Vanguard group2.44M2.45%$7.26M
Bioimpact capital1.51M1.52%$4.50M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rosalind advisors1.39M3.19%$4.15M
Ally bridge group (ny)1.47M2.62%$4.40M
Nea management company11.37M2.55%$33.88M
Opaleye management2.65M1.80%$7.88M
Frazier life sciences management7.38M1.03%$22.00M
Checkpoint capital500.09K0.90%$1.49M
Bioimpact capital1.51M0.70%$4.50M
Logos global management lp2.80M0.67%$8.34M
Acuta capital partners260.00K0.65%$774.80K
Vr adviser3.42M0.65%$10.20M

Top Buyers

HolderShares% AssetsChange
Ally bridge group (ny)1.47M2.62%1.47M
Blackrock3.14M0.00%759.41K
Logos global management lp2.80M0.67%600.00K
Rosalind advisors1.39M3.19%465.56K
Tejara capital405.99K0.44%368.51K

Top Sellers

HolderShares% AssetsChange
Rubric capital management lp5.03M0.39%-537.19K
Propel bio management---260.00K
Simplify asset management---200.00K
Landscape capital management605.44K0.15%-134.69K
Renaissance51.90K0.00%-64.94K

New Positions

HolderShares% AssetsChangeValue
Ally bridge group (ny)1.47M2.62%1.47M$4.40M
Acuta capital partners260.00K0.65%260.00K$774.80K
Corebridge financial31.59K0.00%31.59K$94.15K
Mirae asset global etfs21.15K0.00%21.15K$63.03K
Hsbc19.61K-19.61K$60.80K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Steward partners investment advisory-25.00
Citadel advisors-2.20K
Metropolitan life insurance co/ny-2.33K
Sg americas securities-14.59K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20249725.97%58,119,8883.96%571.82%4913.95%1926.67%
Jun 30, 202477-4.94%55,906,6878.43%562.07%4316.22%15-44.44%
Mar 31, 20248124.62%51,561,502-1.29%521.88%37-2.63%2792.86%
Dec 31, 20236518.18%52,235,7087.30%522.16%38100.00%14-17.65%
Sep 30, 202355-48,682,678-0.29%492.01%19-51.28%17142.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.78M2.31%-
iShares Russell 2000 ETF1.40M1.82%-3.15K
Vanguard Institutional Extnd Mkt Idx Tr973.23K1.34%427.35K
Fidelity Small Cap Index605.96K0.83%-11.85K
iShares Russell 2000 Growth ETF338.84K0.44%-
Fidelity Extended Market Index305.20K0.42%48.26K
Vanguard Russell 2000 ETF267.50K0.35%-1.67K
State St Russell Sm/Mid Cp® Indx NL Cl C261.63K0.34%-12.10K
iShares Russell 2000 Value ETF240.09K0.31%-
Bridgeway Ultra-Small Company Market172.88K0.24%89.00K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 09, 2024GOOD JENNIFER L President & CEOSell$5.59K
Sep 06, 2024GOOD JENNIFER L President & CEOSell$12.78K
Sep 04, 2024GOOD JENNIFER L President & CEOSell$33.21K
Sep 05, 2024GOOD JENNIFER L President & CEOSell$125.31K
Sep 03, 2024GOOD JENNIFER L President & CEOSell$11.68K

Insider Transactions Trends

DateBuySell
2024 Q3-10
2024 Q2-4
2024 Q1--
2023 Q4-1
2023 Q3-3

TRVI Ownership FAQ

Who Owns Trevi Therapeutics?

Trevi Therapeutics shareholders are primarily institutional investors at 57.52%, followed by 1.18% insiders and 41.30% retail investors. The average institutional ownership in Trevi Therapeutics's industry, Biotech Stocks , is 44.70%, which Trevi Therapeutics exceeds.

Who owns the most shares of Trevi Therapeutics?

Trevi Therapeutics’s largest shareholders are Nea management company (11.37M shares, 11.43%), Frazier life sciences management (7.38M shares, 7.42%), and Rubric capital management lp (5.03M shares, 5.05%). Together, they hold 23.89% of Trevi Therapeutics’s total shares outstanding.

Does Blackrock own Trevi Therapeutics?

Yes, BlackRock owns 3.15% of Trevi Therapeutics, totaling 3.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.34M$. In the last quarter, BlackRock increased its holdings by 759.41K shares, a 31.97% change.

Who is Trevi Therapeutics’s biggest shareholder by percentage of total assets invested?

Rosalind advisors is Trevi Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.19% of its assets in 1.39M Trevi Therapeutics shares, valued at 4.15M$.

Who is the top mutual fund holder of Trevi Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Trevi Therapeutics shares, with 2.31% of its total shares outstanding invested in 1.78M Trevi Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools